UBS Group AG - ADDEX THERAPEUTICS LTD ownership

ADDEX THERAPEUTICS LTD's ticker is ADXN and the CUSIP is 00654J107. A total of 6 filers reported holding ADDEX THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ADDEX THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$28
-99.7%
74
-99.5%
0.00%
Q4 2022$9,151
+52.5%
14,526
+106.5%
0.00%
Q3 2022$6,000
-33.3%
7,033
-11.6%
0.00%
Q2 2022$9,000
-35.7%
7,954
+183.5%
0.00%
Q1 2022$14,000
-87.2%
2,806
-83.8%
0.00%
Q4 2021$109,000
-6.8%
17,300
+33.1%
0.00%
Q3 2021$117,000
-4.1%
13,000
+2.2%
0.00%
Q2 2021$122,000
+369.2%
12,715
+404.6%
0.00%
Q1 2021$26,000
+2500.0%
2,520
+2420.0%
0.00%
Q4 2020$1,000
-92.9%
100
-91.3%
0.00%
Q3 2020$14,0001,1440.00%
Other shareholders
ADDEX THERAPEUTICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 5,648,690$830,0000.04%
New Leaf Venture Partners, L.L.C. 50,000$40,0000.02%
FNY Investment Advisers, LLC 22,500$17,0000.01%
ARMISTICE CAPITAL, LLC 320,000$256,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 19,957$16,0000.00%
Citadel Advisors 12,803$10,0000.00%
TWO SIGMA SECURITIES, LLC 12,076$10,0000.00%
Renaissance Technologies 29,547$24,0000.00%
Tower Research Capital LLC (TRC) 124$00.00%
View complete list of ADDEX THERAPEUTICS LTD shareholders